Biomass is a valuable and limited resource that should be used efficiently. The potential of replacing fossil-based products with bio-based ones produced in biobased industrial systems is huge. One important aim of increasing the share of biobased products is to improve the sustainability of systems for production and consumption. Therefore, it is important to evaluate what solutions are available to improve the sustainability performance of bio-based industrial systems, and if they also bring negative impacts. The thesis focuses on assessing the role of biogas solutions in developing sustainable bio-based systems. Such assessments are often quite narrow in their scope and focus on quantitative environmental or economic aspects. This thesis aims at also including feasibility related aspects involving the contextual conditions that are assessed more qualitatively. Biogas solutions are identified as a versatile approach to treat organic materials which are generated in large volumes in bio-based industrial systems. The results show that biogas solutions in bio-based industrial systems (i) improve circular flows of energy and nutrients, (ii) are especially viable alternatives when the quality of the by-product streams become poorer, and (iii) may improve the profitability of the bio-based industrial system. To perform better assessments of these systems, it seems valuable to broaden the set of indicators assessed and include feasibility-related indicators, preferably through the involvement of relevant stakeholders as they contribute with different perspectives and can identify aspects that influence the sustainability in different areas. Future studies could benefit from applying those broader assessments on more cases to build on a more generalisable knowledge base.

With the advent of fluorescence microscopy and image analysis, quantitative information from images can be extracted and changes in cell morphology can be studied. Microscopy-based morphological profiling assays with multiplexed fluorescent dyes, like Cell Painting, can be used for this purpose. It has been shown that morphological profiles can be used to train AI models to classify images into different biological mechanisms. Hence, the goal of this project was to study the possibilities for Deep Learning models and Convolutional Neural Networks to distinguish between different classes of kinase inhibitors based on their morphological profiles. Three different Convolutional Neural Network architectures were used: ResNet50, MobileNetV2, and VGG16. They were trained with two different inputs and two different optimisers: Adam and SGD. Also, a comparison between the performances with and without Transfer Learning through ImageNet weights was executed. The results indicate that MobileNetV2 with Adam as an optimiser performed the best, with a micro average of 0.93 and higher ROC areas compared to the other models. The study also highlighted the importance of utilizing Transfer Learning.

En pilotanläggning för ultrafiltering testas nu i Norrvattens reningsprocess för att undersöka ifall den kan användas som en tredje mikrobiologisk barriär i reningsprocessen. Målet med detta projekt är att testa membranets kapacitet att filtrera bort viruspartiklar men även membranet generella reduktionsförmåga för andra mikrobiologiska och kemiska kontamineringar. För att hitta lämpliga kandidater att använda sig av för att mäta reduktionskapaciteten av membranet har en litteraturstudie samt experimentell testning av råvattnet genomförts. OD mätningar på bakteriekulturer samt plackbildandeenheter (PBE) har undersökt för att se om bakteriofager kan finnas i proven. Ungefär 9000 L av ingående och utgående vatten från ultrafilteringen har koncentrerats med hjälp av ett elektropositivt filter som senare har eluerats och ultracentrifugerats. Pellet från ultracentrifugeringen har testat för virusdetektion med hjälp av PCR, qPCR samt PBE. TOC och absorbansmätningar har också genomförts på ingående och utgående vatten från ultrafiltermembranet. Slutligen utfördes ett bänkskaleexperiment för att undersöka hur väl filtret reducerade MS2 fager i utgående vatten. Den inledande testningen visade att plantviruset PMMoV och Pseudomonas fager kan vara bra kandidater att använda sig av för att mäta virusreduktionen över ultrafiltermembranet. När elueringen från ultrafiltreringen testades indikerades en minskad DNA koncentrationen över ultrafiltermembranet med hjälp av Qubit-mätningar. Testningen visade även indikation på att PMMoV reduceras över membranet samt att Pseudomonas fager kan finnas i vattnet. TOC och absorbansmätningarna visade en konstant reduktion över membranet. I bänkskaleexperiment borde enlig teori alla fager stoppas av membranet eftersom viruset är större än porstorleken 20 nm, dock visade experimentell testning på att fager även fanns i utgående vatten från filteringen. Resultat av studien indikerar att mikrobiologiska och kemiska kontamineringar tas bort av membranet, dock för att bestämma den exakta virusreduktionen över membranet och ifall alla kontamineringar större än filters porstorlek (20 nm) tas bort kräver vidare testning.  E. coli fager, som i Livsmedelverket nya restriktioner används för att undersöka mikrobiologiska risker i vattenreningsprocesser, har också testats under studien på vattnet utan positiva utslag. Det kan därför vara av intresse att även undersöka andra fager, så som Pseudomonas fager för att kontrollera dem mikrobiologiska riskerna med vattenrening. / The present study was investigating the effectiveness of the ultrafiltration membrane as third biological barrier in Norrvattens drinking water treatment process, using a pilot scale model. This project aims to test the viral reduction capability of the membrane but also to remove other microbiological and chemical contaminants. To find suitable candidates for measuring the reduction capability, literature research has been performed as well as experimental testing of the raw water coming into the treatment plant and the backwash water from the membrane. Bacterial growth analysis using optical density (OD) measurements and plaque forming unit (PFU) has been performed to investigate the presence of bacteriophages. Approximately 9000 L of incoming and outgoing water from the ultrafiltration membrane has been concentrated using an electropositive membrane which then was eluted and ultracentrifuged. The pellet from ultracentrifugation has been tested for viral detection with PCR, qPCR and plating. TOC and absorbance measurement was also performed on the ingoing and outgoing water from the ultrafiltration pilot plant. Finally, a bench-scale experiment was performed using MS2-spiked water to investigate how well the filter reduced MS2 phages in the outgoing water.  The initial testing of the raw and backwash water showed that the plant virus Pepper Mild Mottle Virus (PMMoV) and Pseudomonas phages may be good candidates to use when evaluating the ultrafiltration membrane. When testing the eluate from the ultrafiltration pilot plant a reduction was seen in the starting DNA concentration when comparing the inlet and outlet water to the ultrafiltration pilot plant. The testing gave indications of a reduction of PMMoV and presence of Pseudomonas phages. The bench-scale experiment was hypothesized to stop all viral particles since according to theory the virus should be stopped by the membrane due to its pore size, but experimental testing indicated viruses in the outgoing water from the membrane as well. TOC and absorbance measurements showed a constant reduction over the membrane. The result of the study indicates that microbiological and chemical contaminants are removed by the filter, however, to determine the exact viral reduction potential of the filter and if all contaminant over the size of 20 nm is removed further testing is required.  No indications were seen for Escherichia coli (E. coli) phages in the water throughout the study, which in Livsmedelverket’s (The National Food Agency) new regulations is used for determining the microbiological risks in water treatment processes. It may be of interest to investigate the possibility to also look for other type of phages to determine the microbiological risks, for example Pseudomonas phages which has been seen in this study.

Antibodies have become indispensable tools in diagnostics, research and as therapeutics. There are several strategies to generate monoclonal antibodies (mAbs) in order to avoid the drawbacks of polyclonal antibodies (pAbs) for therapeutic use. Moreover, the growing interest in precision medicine requires a well-characterized target and antibody to predict the responsiveness of a treatment. This thesis describes the use of epitope information and display technologies to generate and characterize antibodies. In Paper I, we evaluated if the epitope information of a well-characterized pAb could be used to generate mAbs with retained binding characteristics. In Paper II, the epitope on the complement protein C5 towards Eculizumab was mapped with surface display, the results of which explained the non-responsiveness of Eculizumab treatment among a patient group due to a mutated C5 gene. With this in mind, we showed efficacy in treatment of the mutated C5 variants using a drug binding to another site on C5, suggesting that our approach can be used to guide treatment in precision medicine. In Paper III, a Gram-positive bacterial display platform was evaluated to complement existing platforms for selection of human scFv libraries. When combined with phage display, a thorough library screening and isolation of nano-molar binders was possible. In Paper IV, a solid phase method for directed mutagenesis was developed to generate functional affinity maturation libraries by simultaneous targeting of all six CDRs. The method was also used to create numerous individual mutants to map the paratope of the parent scFv. The paratope information was used to create directed libraries and deep sequencing of the affinity maturation libraries confirmed the viability of the combination approach. Taken together, precise epitope/paratope information together with display technologies have the potential to generate attractive therapeutic antibodies and direct treatment in precision medicine. / <p>QC 20170418</p>

Therapeutic proteins, a.k.a. biopharmaceuticals, are most commonly produced in expression systems derived from Chinese Hamstery Ovary (CHO) cells, thanks to great capacity of post-translational modifications like secretation, folding and glycosylation. The engineering of cells for regulation of protein expression has many options including knock-in and knock-out of genes, epigenetic studies or improvement of the expression casette of the protein of interest by e.g. promotor variants or modifications of the 5’ and 3’ untranslated region (UTR). The 3’-UTR is therefore a good optimization candidate for attempting to achieve increased expression of therapeutic proteins. The final aim of this study was to identify and design 3’-UTRs for improved expression of therapeutic proteins in HyClone™ CHO cells from GE Healthcare Bio-Sciences AB (GEHC). The impact goal is to increase the efficiency and lower the costs for pharmaceutical companies when producing biopharmaceuticals in the HyClone™ CHO cell line, leading to increased accessibility of monoclonal antibodies (mAbs) on the pharmaceutical market. The study was initiated with bioinformatic analysis of the CHO cell transcriptome from a set of RNA-seq data of HyClone™ CHO to find high expressing, context independent genes. The 3’-UTRs from the best candidate genes were used for construction of plasmids for expression of a Fc-eGFP fusion protein. Nine selected 3’-UTRs were designed, synthesized and cloned into a parent plasmid (pGE0520) creating nine plasmid variants (pGE0523-531). The constructed plasmids were used for evaluation with site directed integration (SDI) into the HyClone™ CHO cell line and expression analysis were performed by flow cytometry and antibody titer measurements from cells with successfully integrated plasmid sorted by fluorescence-activated cell sorting (FACS).   Result show a significant effect on protein expression when using different variants of 3’-UTRs. Two variants, pGE0524 and pGE0526, competing with the parent plasmid in expression levels and integration efficiency from SDI, making them candidates for further investigations against the parent plasmid. Results also show good correlation between flow cytometry data from pre- and post-sorting, which can make research for further 3’-UTRs more efficient by evaluations and prediction of expression levels before cell sorting.

Main purpose of this study was to increase protein expression in Chinese hamster ovary (CHO) cells by improving protein secretion of translated proteins. The goal was to find signal peptides from the screening of signal peptide libraries for improvement of protein secretion using a CHO-cell express selection system. Biopharmaceutical products, proteins such as monoclonal antibodies (mAbs), are most commonly produced using mammalian expression systems such as the expression in CHO cells. The posttranslational modifications of the proteins being expressed in CHO cells are similar to the expressional modifications in human cells, why the CHO cells are suitable for production of proteins used for human therapy. The expression of proteins in the cell is a complex mechanism, fundamentally depending on the DNA sequences in the cell nucleus. Secretion of translated proteins has been showed to be a bottleneck when improving expression. Secretion is initiated by the signal peptide, a n-terminal prolongation of the protein that is recognized by a signal recognition particle (SRP) when being translated by the ribosome. The sequence and structure of the signal peptide has been proved to affect secretion and altering the signal peptide could improve secretion even when changing signal peptide between different species. Designing variants of the signal peptides and analyzing protein expression might lead to improvements of the construct design and more protein produced from the cells, which would save time, money and material for the producer. To construct plasmids containing the gene of interest (GOI) and different signal peptides, several gene cloning methods were used. The plasmids were amplified using Escherichia coli (E. coli) transformation. The constructs were expressed by transfection into the CHO cell genome, and expression were analyzed using flow cytometry. When analyzing expression of a Fc-fusion protein with 5 different signal peptides, the signal peptide Azurocidin is the one showing highest expression levels in this study. In addition, IgG kapa and Albumin signal peptides did not show as high protein expression levels, even if they were better than the L1d and H5b signal peptides. Since signal peptides are exchangeable between proteins and species, it might be that Azurocidin is improving secretion and protein expression with other proteins than Fc-fusion proteins which would be an interesting aspect for further studies. When altering signal peptides with library sequences, the experimental challenges were crucial for the protein expression results and due to these issues, no library sequence could be seen to conquer others when it comes to protein expression levels. Transfection and cultivation procedures needs to be studied and improved before being able to draw conclusions about which signal peptide library sequences that might improve secretion and increase the protein expression.

This Master Thesis was conducted at Octapharma AB in Stockholm. Anticomplementary activity (ACA) is a measure of the product’s abilities to activate the complement system. IgG aggregates are mainly responsible for this activation. Two different performances of a method for determination of ACA in Octagam® are available. The two performances are based on the reference method for test of ACA in immunoglobulins in the European Pharmacopoeia Commission Guideline 6.0 (chapter 2.6.17). The method is carried out either in test tubes or on microtiter plates. The test tube method can be performed either in a manual manner or modified, being more automated. The latter performance has been applied in this study. The plate method is more automated than both of the tube methods. The plate method and the manual tube method have earlier seemed to result in different outcomes, which was the basis for this thesis. The plate method and the modified test tube method have been compared and robustness parameters have been studied in order to see which factors influence on the end result. The adequacy of using Human Biological Reference Preparation (human BRP) as a control for the ACA method in general has also been investigated. Samples of the product are outside the scope of this thesis and have not been investigated. According to this study, the plate method and the modified tube method are not comparable with regard to complement titration results and to ACA of the BRP control. A higher precision is gained with the plate method. This in combination with the higher degree of automation makes the plate method advantageous in several aspects. When it comes to the robustness of the ACA method in general, the sheep red blood cells (SRBC) used are critical. Haemolysin dilution and complement activity seem to be critical as well. Human BRP is, according to this study more adequate as a reference for the plate method than for the tube method. An In house control is believed to be more representative to the ACA method in general as it is of the same nature as the samples analysed, in contrast to the human BRP.

Virtually all extracellular proteins in humans are glycoproteins and likewise are many biopharmaceuticals. The glycosylation is directly correlated to biological function and stability of these proteins. The ability to isolate glycoproteins is thus of great importance in many applications. The most common isolation method for glycoproteins is affinity chromatography using lectins, a ubiquitous and versatile group of carbohydrate-binding proteins. The lectin Concanavalin A (ConA) has long been used for this purpose but suffers from undesired leakage into the eluate, causing an inquiry of alternative chromatography ligands or optimization of the ConA resin.In this study, a total of 20 different lectins, including ConA, were evaluated and compared in terms of suitability as ligands in affinity chromatography for glycoprotein isolation. The lectins’ binding to glycoproteins were studied, mainly through microtiter plate binding assays using a monoclonal IgG1 antibody and Conalbumin (Ovotransferrin). Further, sugar-specificities and potential eluting sugars for the lectins were examined through inhibition with eight different carbohydrates. Additionally, the glycoprotein binding and leakage of ConA columns were examined, and a potential leakagereducing treatment of ConA resin evaluated.ConA was found to be superior in binding to the investigated glycoproteins but exhibited a limited binding when immobilized to an agarose resin. This discrepancy is likely a consequence of structurally hidden glycans on the used glycoproteins and requirements of long residence time when used in a chromatographic setting. Binding competition with several sugars were investigated with a similar microtiter plate binding assay. This method displayed potential to predict the behaviour of sugars and their suitability as eluting agents in a chromatography column. The best eluting sugar for ConA was showed to be methylmannoside, ideally in combination with methylglucoside. Lastly, evaluation of ConA columns with a crosslinking glutaraldehyde-treatment showed that the ConA ligand leakage may be significantly reduced, although further studies and optimizations are needed.This study thus presents a repertoire of lectins and their differences in terms of glycoprotein-binding and sugar-specificity, as well as evaluations of ConA columns’ efficiency and potential leakage-prevention.

Characterization of the pore structure is a crucial part in themanufacturing of porous media used for purification of biologicalpharmaceuticals. This project took place at Cytiva in Uppsala and aimedat optimizing a newly developed method in pore structurecharacterization called size-exclusion quantification NMR (SEQ-NMR). Bymeasuring with diffusion NMR on a polymer solution before and afterequilibration with a material of interest the pore structure of thematerial can be determined. This project aimed at reducing the durationof a SEQ-NMR experiment while examining the performance of the methodduring different conditions with the goal of making the methodapplicable for quality control procedures. The method was optimizedboth by simulations and by experimental diffusion NMR measurements. Itwas discovered that the performance of the method could be improved byhaving an optimal mixture of the polymer solution and duringexperiments distributing ten measurement points with linear spacing.With these parameters optimized the duration of the method could bereduced with 22 hours landing on a total duration of 8 hours. Theduration combined with the complexity of the method still makes themethod unsuitable for use in quality control of porous media. Despitethe small possibility of SEQ-NMR being a quality control method thisproject has proven the method to be both reproducible and sensitive.

Antibodies are the gold standard molecular recognition elements and a cornerstone of molecular biology. They are used in immunoassays to precisely measure a specific analyte, but certain targets are especially challenging. Difficult targets include small molecules and molecules that do not induce an immune response. Aptamers are short oligonucleotides that can form 3-dimensional structures and bind targets with high specificity. Aptamers are smaller and more flexible than antibodies and could therefore solve this problem. In contrast to antibodies, aptamers are synthetically produced, so they can have affinity for molecules that do not induce an immune response. This also makes them cheaper, faster and more ethical to produce. They are also easily modified and have the ability to renature and can therefore be reused.  Our conclusions are that aptamers can outperform antibodies, especially for small molecule targets, and that the synthetic production of aptamers gives them a further advantage over antibodies. Our report compares several different types of detection methods that use aptamers and we conclude that fluorescence-based methods are the most easy to use with basic lab equipment, can be made similar to the ELISA kits in addition to giving highly sensitive detection. We describe a variety of fluorescence-based detection strategies but the optimal method will depend on the specific aptamer and target. The report also includes an ethical analysis where antibodies and aptamers are compared. This report is commissioned by Mercodia AB, a company that develops, manufactures and distributes immunoassays for biomarkers within the field of metabolic disorders. They commissioned this report in order to give an overview of how aptamers interact with their target, and also to compare aptamer-based detection strategies with sensitivity prioritized over selectivity.  This was done by literature research.